Gujarat's most trusted NABL-accredited partner for pharmaceutical calibration, GMP validation, EHS compliance, and regulatory consulting. Serving 500+ pharma companies since 2004. Accepted by WHO · EU GMP · FDA · CDSCO.

GMP Compliant
WHO · EU · FDA
NABL CC-2480
Since 2004
— WHY IT MATTERS —
In pharma, every measurement affects a patient. A miscalibrated instrument is not just a compliance gap — it's a safety risk, a regulatory violation, and a financial liability.
Inaccurate instruments mean wrong doses, contaminated batches, and incorrect potency. A miscalibrated balance by 0.1 g can render an entire batch ineffective or toxic — directly harming patients.
Schedule M India (2023), WHO GMP, EU GMP Annex 1, and FDA 21 CFR Part 211.68 mandate that every measuring instrument be calibrated with NABL-traceable certificates. No calibration = GMP violation.
US FDA, EU EMA, and WHO prequalification require NABL-traceable calibration records during facility inspection. Missing certificates result in import alerts, port rejection, and loss of export access.
Every tablet weight, capsule fill, and API concentration depends on calibrated instruments. Drift in a balance or temperature sensor causes batch-to-batch variation — leading to OOS results.
During regulatory inspections, auditors specifically ask for NABL-traceable calibration certificates. Missing records = 483 observations, warning letters, or manufacturing licence suspension.
A batch recall due to instrument error costs ₹10–50 crore. Annual NABL calibration costs a fraction of that — it is the cheapest insurance against regulatory action and product recall.
— SCOPE OF CALIBRATION —
Every measuring instrument that affects product quality or patient safety must be NABL calibrated. Click any instrument to learn more.
— STANDARDS & COMPLIANCE —
Every calibration and validation at Prism follows a documented, traceable procedure aligned with global pharmaceutical regulatory requirements. Our NABL-accredited certificates satisfy WHO GMP, EU GMP Annex 1, FDA, CDSCO, and Schedule M India audit requirements.
WHO GMP
Good Manufacturing Practice
EU GMP Annex 1 (2022)
Sterile Medicinal Products
FDA 21 CFR Part 211
Finished Pharmaceuticals
Schedule M India (2023)
Indian GMP Standard
ISO/IEC 17025:2017
NABL Accreditation Standard
ICH Q7 / Q10
API & Pharma Quality Systems
NABL CC-2480
Prism Accreditation Number
ISO 9001:2015
Quality Management System
Prism holds NABL accreditation CC-2480 under ISO/IEC 17025:2017, recognized under the ILAC MRA agreement. Our pharma calibration certificates carry the same legal weight as any NABL-accredited lab worldwide — valid for WHO GMP, EU GMP Annex 1, FDA 21 CFR Part 211.68, CDSCO, and Schedule M India (2023) audits.
500+
Pharma Companies Served
200+
Instrument Types Covered
— NON-NABL CALIBRATION —
In addition to our NABL-accredited calibration, Prism also provides non-NABL calibration for pharmaceutical instruments. Non-NABL calibration is ideal when a formal accreditation certificate is not required — offering faster turnaround and cost-effective pricing with the same trained engineers and traceable reference standards.
All calibrations use NPL/BIPM-traceable reference standards regardless of whether the certificate is NABL or non-NABL — same accuracy, same engineers.
Non-NABL calibration jobs are typically completed faster — ideal for urgent maintenance, breakdown situations, or bulk batch calibration across your plant.
Non-NABL calibration is priced lower than accredited calibration — the right choice for internal maintenance, R&D labs, or pre-clinical instruments.
Available both at our Ahmedabad lab and as onsite service across Gujarat — with or without NABL certification as per your specific requirement.
— OUR SERVICES FOR PHARMA —
Calibration · Validation · EHS & Audit · Consulting — one NABL-accredited partner.
NABL CC-2480 calibration for all pharma instruments — temperature, pressure, mass, electrical — with WHO/FDA/EU GMP accepted certificates.
Full GMP equipment and facility validation — DQ/IQ/OQ/PQ documentation per EU GMP Annex 1, WHO TRS 970, Schedule M India, and FDA 21 CFR.
Environmental, health & safety compliance for pharma plants — GPCB environmental, safety audits, energy audits, HAZOP, and stack emission testing.
Regulatory and management consulting — ISO, NABL, HACCP certifications and GMP documentation support with minimal production disruption.
— RISKS OF NON-COMPLIANCE —
The cost of not calibrating is always higher than the cost of calibration.
US FDA cites missing or non-traceable calibration as a critical GMP deficiency — resulting in import alerts that can shut down US export business.
WHO prequalification inspectors require current NABL certificates for all critical instruments. Missing = prequalification revoked.
CDSCO drug inspectors check calibration records. Expired or missing certificates can lead to batch condemnation and production stop.
EU GMP inspectors verify instrument calibration during facility audit. Non-compliant facilities are placed on the EU non-compliant list.
Drifted instruments cause Out-of-Specification results. Every OOS triggers mandatory investigation — costly production halt.
A product recall due to instrument-related quality failure costs ₹10–50 crore and permanently damages brand reputation in regulated markets.
Why Choose Prism
Since 2004, every NABL calibration certificate and GMP validation report issued by Prism has been accepted by WHO GMP, EU GMP, FDA, and CDSCO auditors — no rejections, no rework, no compliance gaps.
Onsite Coverage
NABL-certified engineers travel to your pharma facility with portable reference standards — no instrument removal, zero production downtime.
NABL CC-2480 · 500+ Pharma Companies · Est. 2004
Onsite service · Same week appointment · 5–7 day report delivery
— CLIENT TESTIMONIALS —
Prism validated all our clean rooms under EU GMP Annex 1 (2022) and WHO TRS 970. Every report was accepted in our US FDA and WHO GMP audits — zero observations in 5 consecutive inspections.
Dr. Priya Shah
Clean room DQ/IQ/OQ/PQ for our new API block — particle counting, HEPA PAO testing, ACH and T&H mapping done onsite. Report issued in 5 days, accepted directly in EU GMP inspection.
Rajesh Patel
Annual requalification across 12 Grade B/C rooms by Prism. GMP-standard reports with measurement uncertainty. NABL-traceable instruments, professional team, zero rework requests in 6 years.
Kavita Menon
Prism validated all our clean rooms under EU GMP Annex 1 (2022) and WHO TRS 970. Every report was accepted in our US FDA and WHO GMP audits — zero observations in 5 consecutive inspections.
Dr. Priya Shah
Clean room DQ/IQ/OQ/PQ for our new API block — particle counting, HEPA PAO testing, ACH and T&H mapping done onsite. Report issued in 5 days, accepted directly in EU GMP inspection.
Rajesh Patel
Annual requalification across 12 Grade B/C rooms by Prism. GMP-standard reports with measurement uncertainty. NABL-traceable instruments, professional team, zero rework requests in 6 years.
Kavita Menon
Prism validated all our clean rooms under EU GMP Annex 1 (2022) and WHO TRS 970. Every report was accepted in our US FDA and WHO GMP audits — zero observations in 5 consecutive inspections.
Dr. Priya Shah
Clean room DQ/IQ/OQ/PQ for our new API block — particle counting, HEPA PAO testing, ACH and T&H mapping done onsite. Report issued in 5 days, accepted directly in EU GMP inspection.
Rajesh Patel
Annual requalification across 12 Grade B/C rooms by Prism. GMP-standard reports with measurement uncertainty. NABL-traceable instruments, professional team, zero rework requests in 6 years.
Kavita Menon
— FAQs —
— GET IN TOUCH —
Calibration before a WHO audit, clean room validation, or ISO consulting — tell us what you need and we'll respond within 24 hours.